The guidelines should help physicians address comorbidities among chronic migraine patients.
News
Cross-linked hyaluronic acid (HA) injections reduced Visual Analog Scale of Pain (VAS) scores in patients with neuropathic pain.
Even in remission, many patients with RA experience neuropathic pain-like symptoms.
Pain relief lasted for 24 weeks vs. two weeks with the classical GON block technique.
Frequency and intensity was reduced with the reduction of TC and LDL cholesterol levels.
Depression, substance abuse, and suicidal ideation are commonly reported in patients who have chronic pain.
How adolescents approach their chronic pain condition has an effect on how they will experience their condition in adulthood.
A combination of nonpharmacologic and pharmacologic therapies will help manage this far-reaching disorder.
A simple lipid panel may distinguish those with episodic migraine.
Commonly used antidepressants appear to target specific neurotransmitters in the brain that regulate chronic pain symptoms.
Zecuity (sumatriptan iontophoretic transdermal system) is indicated for the treatment of migraine with or without aura in adults.
Corticosteroid injections were ineffective for people with spinal stenosis.
Researchers have developed clinical recommendations regarding headaches in pregnant women.
The FDA has approved labeling updates for Oxycontin extended-release tablets for patients aged 11 and older.
The report revealed that approximately 25.3 million adults had pain every day for the preceding 3 months.
The task force hopes to develop protocols to curb abuse of opioids.
Chronic drinking only causes further deterioration, U.S. physicians warn.
In the HF10 therapy group, 85% of back pain and 83% of leg pain patients experienced a 50% reduction in pain or greater.
Researchers observed a dose-dependent reduction in pain in patients with diabetic peripheral neuropathy.
Many physicians don’t ask about alternative therapies, so patients don’t disclose them.
People with a history of smoking or abusing drugs are at the highest risk of using opioids for the long-term.
Shared genetic variants found in migraineurs were actually protective against heart disease.
Those who have not gained relief from standard migraine treatment may want to look into surgery.
Physicians, as well as patients, are unaware and misinformed of the dangers that come with opioid use
New oral naxalone sustained release (NSR) capsule allows for successful treatment of opioid-induced constipation.
Insurance companies may not cover the cost for hyperbaric oxygen therapy since it is not FDA-approved yet.
Napping is often used as a coping mechanism for people with fibromylagia.
The recommended dose of Zomig Nasal Spray is 2.5mg for patients 12 years and older.
Use of ultrasound guidance in interventional pain procedures is still lacking.
Injectable medications have shown promise in early trials, but more research is needed.
